Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Negotiating renal dysfunction when treating patients with heart failure
Valentina Carubelli1, Marco Metra1, Lars H Lund2
1a Division of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health , University and Civil Hospital of Brescia , Brescia , Italy.
Insights
Chronic kidney disease (CKD) is common in heart failure (HF), with no specific treatments for cardiorenal syndrome. This review explores heart-kidney interactions and therapeutic challenges in managing these intertwined conditions.
Area of Science:
- Cardiology
- Nephrology
- Cardiorenal Medicine
Background:
- Chronic kidney disease (CKD) is a frequent comorbidity in heart failure (HF).
- Cardiorenal syndrome lacks specific treatments, despite the close pathophysiological link between heart and kidney function.
- CKD adversely affects HF outcomes, while cardiovascular events are leading causes of mortality in CKD patients.
Purpose of the Study:
- To review the interaction between heart and kidney function.
- To describe the consequences of cardiorenal syndrome.
- To focus on the application of current therapeutics for cardiorenal syndrome.
Main Methods:
- Literature review of cardiorenal syndrome.
- Analysis of pathophysiological mechanisms.
- Discussion of therapeutic management challenges.
Main Results:
- Multiple mechanisms, including hemodynamic, neurohormonal, and inflammatory mediators, contribute to cardiorenal syndrome.
- Managing HF drugs in CKD patients presents challenges, such as reduced diuretic response and increased risk of kidney function decline.
- Balancing cardiac and renal outcomes is a critical aspect of clinical practice.
Conclusions:
- The intricate relationship between heart and kidney necessitates a careful therapeutic approach.
- Optimizing treatment for cardiorenal syndrome requires a nuanced understanding of both cardiac and renal physiology.
- Further research is needed to develop targeted therapies for cardiorenal syndrome.
Introduction:
Chronic kidney disease (CKD) is one of the most prevalent comorbidities in HF, and no specific treatment is still available for the so-called cardiorenal syndrome. Areas covered: The aim of this review is to describe the interaction of heart and kidney function and the consequences of cardiorenal syndrome, focusing on the use of available therapeutics. Expert commentary: The presence of CKD has been associated with adverse outcomes in HF regardless of ejection fraction. On the other hand, cardiovascular events are the most common causes of morbidity and mortality among CKD patients, reflecting the close pathophysiological crosstalk between these organs. Multiple mechanisms are involved in the development of cardiorenal syndrome, including hemodynamic, neurohormonal and inflammatory mediators. The management of several HF drugs is a challenge in the presence of CKD mainly due to blunted diuretic response and increased risk of worsening of kidney function. Therefore, finding a balance between the optimization of cardiac and renal outcomes is a real negotiation in the everyday clinical practice.
More Related Videos
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics